COVID-19对严重不受控制的喘成本和生物使用的影响
Najm S Khan1, Elizabeth Rubin2, Bernard McKenna3
1From the Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
由于COVID-19大流行,严重失控喘 (SUA) 患者的医疗保健费用降低,但处方费用增加. 在此期间,生物治疗的使用也显著下降.
科学领域:
- 肺部医学 肺部医学
- 卫生经济学 卫生经济学
- 流行病学 流行病学
背景情况:
- 严重不受控制的喘 (SUA) 造成了严重的经济负担,往往需要生物治疗.
- COVID-19大流行对喘相关成本和生物利用的影响尚未评估.
研究的目的:
- 调查假设在COVID-19大流行期间,严重不受控制的喘的成本和生物使用量下降.
主要方法:
- 从2017年1月到2021年12月,分析了严重不受控制的喘患者的医疗成本和生物使用情况.
- 利用来自大型管理护理组织的索赔数据和来自罗伯特·伍德·约翰逊·巴拿巴健康的电子健康记录.
- 数据按提供者专业 (初级保健医生和专家) 分层.
主要成果:
- 在所有护理群体中,严重不受控制的喘患者的总医疗费用在疫情期间下降了 (34%-45%的减少).
- 住院和门诊费用下降,处方费用增加.
- 生物使用量在流行前一直在增加,但在流行前减少了两倍,并且仍然很低.
结论:
- 随着COVID-19大流行,住院和门诊的费用降低,但严重的非控制性喘患者的处方费用增加.
- 在严重不受控制的喘患者中,生物利用在疫情期间显著下降,并保持低.
更多相关视频
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
相关概念视频
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
COPD: Management Using Bronchodilators and Corticosteroids
